HOOKIPA Pharma Inc. (NASDAQ:HOOK), a biopharmaceutical firm specializing in immunotherapies for oncology and infectious illnesses, has been making vital strides…
Our selection of the week's biggest research news and features sent directly to your inbox. Enter your email address, confirm you're happy to receive our emails.